Notice: This company has been marked as potentially delisted and may not be actively trading. CinCor Pharma (CINC) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CinRx Pharma portfolio company CinDome raises $40M toward Series B roundMay 28, 2024 | bizjournals.comDelveInsight Business Research, LLP: Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsightApril 26, 2024 | finanznachrichten.deGlobal Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsightApril 26, 2024 | tmcnet.comCinCor Pharma Inc.March 22, 2024 | thestreet.comPurdue Pharma to plead guilty in $8bn opioid settlementDecember 12, 2023 | bbc.comImpel Pharmaceuticals hit by another C-suite departureDecember 6, 2023 | bizjournals.comCatalyst Pharma's Finance Chief to Retire, Be Succeeded by Impel's CFODecember 4, 2023 | marketwatch.comSmall Pharma Inc. (DMT.V)November 4, 2023 | ca.finance.yahoo.comAbivax Readies $250 Million U.S. IPO For Drug PipelineOctober 20, 2023 | msn.comDiabetic Kidney Disease Global Market Report 2023June 9, 2023 | uk.finance.yahoo.com8-K: IMPEL PHARMACEUTICALS INCMay 11, 2023 | marketwatch.comChronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsightMay 9, 2023 | finance.yahoo.comFinancial Results for the Year Ended 31 December -3-April 25, 2023 | finanznachrichten.deCinCor Pharma, Inc. (NASDAQ:CINC) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of CinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) have received an average recommendation of "Hold" from the six brokerages that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and two have issued a buyMarch 20, 2023 | marketbeat.comNASDAQ Biotechnology IndexMarch 16, 2023 | reuters.comHOOKIPA Pharma Appoints Terry Coelho to its Board of DirectorsMarch 13, 2023 | finance.yahoo.comBoothbay Fund Management LLC Purchases Shares of 13,718 CinCor Pharma, Inc. (NASDAQ:CINC)Boothbay Fund Management LLC purchased a new stake in CinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 13,718 shares of the company's stock, valued at approximately $450,000. A numbeMarch 2, 2023 | marketbeat.comTrading was temporarily halted for "CINC" at 07:02 PM with a stated reason of "News pending."February 24, 2023 | marketbeat.comCinCor Pharma, Inc. (NASDAQ:CINC) Given Average Recommendation of "Moderate Buy" by AnalystsCinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) has been given a consensus rating of "Hold" by the six analysts that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the companFebruary 23, 2023 | marketbeat.comCinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of BaxdrostatFebruary 21, 2023 | finance.yahoo.comState Board of Administration of Florida Retirement System Invests $230,000 in CinCor Pharma, Inc. (NASDAQ:CINC)State Board of Administration of Florida Retirement System purchased a new position in CinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 7,000 shares of the company's stoFebruary 15, 2023 | marketbeat.comThere's a Lot to Love About Mineralys' Valentine's Day IPO (CINC)MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 millionFebruary 13, 2023 | marketbeat.comCinCor Pharma, Inc. (NASDAQ:CINC) Short Interest Down 74.7% in JanuaryCinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 338,600 shares, a decline of 74.7% from the January 15th total of 1,340,000 shares. Approximately 2.0% of the company's stock are short sold. Based on an average trading volume of 577,600 shares, the days-to-cover ratio is currently 0.6 days.February 10, 2023 | marketbeat.comAs demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023February 9, 2023 | msn.comThese 2 Healthcare Stocks Have Doubled in 2023 (CINC)Wouldn’t it be great if a stock had a bulkier capitalization and 2x potential? This is rare but possible for these two small-mid health care stocks.February 1, 2023 | marketbeat.comCinCor Pharma, Inc. (NASDAQ:CINC) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of CinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) have received an average rating of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have givenJanuary 29, 2023 | marketbeat.comCinCor Pharma, Inc. (NASDAQ:CINC) Short Interest Down 38.2% in JanuaryCinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 1,340,000 shares, a drop of 38.2% from the December 31st total of 2,170,000 shares. Based on an average daily volume of 591,500 shares, the days-to-cover ratio is presently 2.3 days. Approximately 7.7% of the company's shares are short sold.January 27, 2023 | marketbeat.comADRs End Higher; AstraZeneca, Barclays Trade ActivelyJanuary 24, 2023 | marketwatch.comBritain's AstraZeneca launches tender offer for CinCor PharmaJanuary 23, 2023 | msn.comAstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.January 23, 2023 | finance.yahoo.comCambridge Investment Research Advisors Inc. Invests $204,000 in CinCor Pharma, Inc. (NASDAQ:CINC)Cambridge Investment Research Advisors Inc. bought a new position in shares of CinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 6,225 shares of the company's stock, valued at approximately $204,00January 16, 2023 | marketbeat.comWill 2023 be the year that pharma M&A makes a comeback?January 12, 2023 | msn.comCinCor Pharma (NASDAQ:CINC) Lowered to Equal Weight at BarclaysBarclays downgraded shares of CinCor Pharma from an "overweight" rating to an "equal weight" rating in a research note on Thursday.January 12, 2023 | marketbeat.comAstraZeneca Is Acquiring CinCor Pharma: Market Values Interesting CVR At $3.21January 12, 2023 | seekingalpha.comAstraZeneca reaches deal to buy CinCor Pharma for up to $1.8 billionJanuary 11, 2023 | bizjournals.comAstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor BuyoutJanuary 10, 2023 | finance.yahoo.comEQUITY ALERT: The M&A Class Action Firm Announces the Investigation of CinCor Pharma, Inc - CINCJanuary 10, 2023 | marketwatch.comAstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor BuyoutJanuary 10, 2023 | finance.yahoo.comCinCor Pharma Target of Unusually High Options Trading (NASDAQ:CINC)CinCor Pharma, Inc. (NASDAQ:CINC - Get Rating) saw some unusual options trading on Tuesday. Stock investors purchased 5,139 put options on the stock. This represents an increase of 922% compared to the typical daily volume of 503 put options.January 10, 2023 | marketbeat.comAstraZeneca buying hypertension-focused CinCor for up to $1.8 billionJanuary 9, 2023 | msn.comAstraZeneca to Buy CinCor Pharma for Up to $1.8 BillionJanuary 9, 2023 | finance.yahoo.comAstraZeneca reaches deal to buy CinCor Pharma for up to $1.8BJanuary 9, 2023 | finance.yahoo.comAstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion DealJanuary 9, 2023 | finance.yahoo.comBiotechs CinCor, Albireo Jump on Takeovers by Larger DrugmakersJanuary 9, 2023 | finance.yahoo.comAstraZeneca agrees to buy U.S.-based CinCor in deal valued at $1.3 billionJanuary 9, 2023 | msn.comAstraZeneca to buy CinCor Pharma for up to $1.8bnJanuary 9, 2023 | thetimes.co.ukAstraZeneca to Buy CinCor Pharma for Around $1.3 billionJanuary 9, 2023 | wsj.comAstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln dealJanuary 9, 2023 | reuters.comThese Stocks Are Moving the Most Monday: CinCor Pharma, Macy’s, Alibaba, and MoreJanuary 9, 2023 | barrons.comAstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal PipelineJanuary 9, 2023 | markets.businessinsider.com Get CinCor Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CINC and its competitors with MarketBeat's FREE daily newsletter. Email Address What This Post-Election Shift Means for Your Investments (Ad)The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important. Click here now to watch the full briefing and prepare for what's next. CINC Media Mentions By Week CINC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CINC News Sentiment▼0.300.48▲Average Medical News Sentiment CINC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CINC Articles This Week▼00▲CINC Articles Average Week Get CinCor Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CINC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXSM News Today BHVN News Today ALKS News Today BBIO News Today RARE News Today PBH News Today OGN News Today PRGO News Today RYTM News Today APLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CINC) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored1971, 1986, 1990… and right nowOne small investment into these three companies at IPO and you’ve outperformed almost any other investment you...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CinCor Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CinCor Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CINC Stock Alerts